Market Tracker

05/22 6:45pm ET

PDL BioPharma Inc (NASDAQ:PDLI)

6.66
Delayed Data
As of May 22
 +0.02 / +0.30%
Today’s Change
6.38
Today|||52-Week Range
10.26
-13.62%
Year-to-Date

Today’s Trading

Previous close6.64
Today’s open6.62
Day’s range6.61 - 6.71
Volume1,337,771
Average volume (3 months)3,999,877
Market cap$1.1B
Dividend yield9.01%
Data as of 3:59pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)+12.05%
Earnings growth (this year)+13.17%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+31.23%
P/E ratio3.5
Price/Sales2.10
Price/Book2.35

Competitors

 Today’s
change
Today’s
% change
SRPTSarepta Therapeutics...+1.96+8.08%
FOLDAmicus Therapeutics ...0.000.00%
ACHNAchillion Pharmaceut...+0.12+1.32%
PRTAProthena Corporation...+0.53+1.58%
Data as of 4:00pm ET, 05/22/2015

Financials

Next reporting dateJuly 29, 2015
EPS forecast (this quarter)$0.52
Annual revenue (last year)$581.2M
Annual profit (last year)$322.2M
Net profit margin55.44%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Peter McLaughlin
Chief Financial Officer &
Vice President
Peter S. Garcia
Corporate headquarters
Incline Village, Nevada

Forecasts